Disseminated Cryptococcosis Following Eculizumab Therapy: Insight Into Pathogenesis
Sign Up to like & getrecommendations! Published in 2023 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofad159
Abstract: Abstract Eculizumab, a recombinant humanized monoclonal antibody (mAb), is used for the treatment of patients (both adults and children) with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. This mAb binds to complement protein 5… read more here.
Keywords: cryptococcosis following; following eculizumab; eculizumab therapy; pathogenesis ... See more keywords
Cryptococcosis among hospitalised patients with COVID‐19: A multicentre research network study
Sign Up to like & getrecommendations! Published in 2022 at "Mycoses"
DOI: 10.1111/myc.13476
Abstract: It is unclear if there is an association between COVID‐19 and cryptococcosis. Therefore, this study aimed to describe the clinical features, risk factors, and outcomes associated with cryptococcosis in hospitalised patients with COVID‐19. The objectives… read more here.
Keywords: hospitalised patients; cryptococcosis following; diagnosis covid; cryptococcosis ... See more keywords